BioSpace News Archive

Eli Lilly and Company (NYSE: LLY) today announced that the U.S. District Court for the Southern District of Indiana ruled in favor of Lilly that the Alimta® (pemetrexed for injection) vitamin regimen patent would be infringed by a competitor that had stated its intent to market alternative salt forms of pemetrexed prior to the patent’s expiration in May 2022.

Supply Clinic, the online marketplace for dental supplies, announced the appointment of Mitch Olan, former COO, CEO, and current Executive Chairman of Dental Care Alliance (DCA), to its Advisory Board

Novadoz Pharmaceuticals, the U.S based sales & marketing affiliate for MSN Labs, based in Hyderabad India, has received FDA approval for their generic version of Febuxostat 40mg and 80mg tablets.

Guardant Health, Inc. announced the company will be participating in the upcoming 38th Annual J.P. Morgan Healthcare Conference in San Francisco, CA.

Adaptive Biotechnologies Corporation, announced the company will be participating in the upcoming 38th Annual J.P. Morgan Healthcare Conference in San Francisco, CA.

SeaSpine Holdings Corporation announced the full commercial launch of the Mariner® Midline Posterior Fixation System.

BraineHealth, an initiative that provides innovation in the medical industry using AI technology, is introducing inEmpathy.

AgriCann Solutions Corp. (the “Company”, “AgriCann” or “ASC”) is pleased to announce entering into a binding Letter of Intent (“LOI”) with CannaHoldCo, Inc.

Navidea Biopharmaceuticals, Inc. announced that on December 26, 2019, the United States District Court, Southern District of New York ruled on several motions related to Navidea and its majority-owned subsidiary, Macrophage Therapeutics, Inc. and Dr. Michael Goldberg that substantially limited the claims that Dr. Goldberg can pursue against Navidea and MT.

OncoImmune, Inc. announced today that its Investigational New Drug application for ONC-392, its novel, next generation anti-CTLA-4 antibody, has been approved by the U.S. Food and Drug Administration.